![](https://endpts.com/wp-content/uploads/2022/05/Bill-Hinshaw-Axcella-social.jpg)
Bill Henshaw, Axcella Health CEO
Axcella reduces workforce by 85%, prioritizes long Covid drug research
After missing its primary goal in Phase IIa trials for its long Covid drug, Axcella Health announced Wednesday that it’s cutting 85% of its workforce …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.